Rationale for Use of an FDA-Cleared Delivery System for Administration of Inhaled Nitric Oxide in Patients Undergoing Magnetic Resonance Imaging

Autor: Salas M, Potenziano JL, Acker J

Publikováno v: Medical Devices: Evidence and Research, Vol Volume 14, Pp 1-7 (2021)

Mauro Salas,1 Jim L Potenziano,2 Jaron Acker3 1Clinical Specialist, Children’s National Health System, Washington, DC, USA; 2Scientific Affairs, Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA; 3Medical Device Marketing, Mallinckrodt Pharmaceutic

Externí odkaz: https://doaj.org/article/af2e74d420c64066a3143b344d1e16f1

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A Randomized, Multicenter, Blinded Pilot Study Assessing the Effects of Gaseous Nitric Oxide in an Ex Vivo System of Human Lungs.

Autor: Hartwig MG; Duke University Medical Center, Durham, NC, USA. matthew.hartwig@duke.edu.; Cardiovascular and Thoracic Surgery, Duke University School of Medicine, Box 3863, Durham, NC, 27710, USA. matthew.hartwig@duke.edu., Klapper JA; Duke University Health System, Durham, NC, USA., Poola N; Mallinckrodt Pharmaceuticals, Hampton, NJ, USA., Banga A; University of Texas Southwestern Medical Center, Dallas, TX, USA., Sanchez PG; University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Murala JS; University of Texas Southwestern Medical Center, Dallas, TX, USA., Potenziano JL; Mallinckrodt Pharmaceuticals, Hampton, NJ, USA.

Publikováno v: Pulmonary therapy [Pulm Ther] 2023 Mar; Vol. 9 (1), pp. 151-163. Date of Electronic Publication: 2022 Dec 13.

Inhaled nitric oxide (iNO) for preventing prematurity-related bronchopulmonary dysplasia (BPD): 7-year follow-up of the European Union Nitric Oxide (EUNO) trial.

Autor: Greenough A; King's College London, London, UK., Decobert F; Centre Hospitalier Intercommunal de Créteil, Créteil, France., Field D; University of Leicester Centre for Medicine, Leicester, UK., Hallman M; University of Oulu and Oulu University Hospital, Oulu, Finland., Hummler HD; Sidra Medicine, Doha, Qatar.; University of Ulm, Ulm, Germany., Jonsson B; Karolinska University Hospital and Institute, Stockholm, Sweden., Sánchez Luna M; Hospital General Universitario 'Gregorio Marañón,'Madrid, Spain., Van Overmeire B; Université Libre de Bruxelles, Brussels, Belgium., Carnielli VP; Polytechnical University of Marche, Ancona, Italy., Potenziano JL; Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA., Mercier JC; Université Paris Diderot, Paris, France.

Publikováno v: Journal of perinatal medicine [J Perinat Med] 2020 Sep 07; Vol. 49 (1), pp. 104-110. Date of Electronic Publication: 2020 Sep 07.

Inhaled nitric oxide for neonates with persistent pulmonary hypertension of the newborn in the CINRGI study: time to treatment response.

Autor: Nelin LD; The Research Institute at Nationwide Children's Hospital, 575 Children's Crossroads, Columbus, OH, 43215, USA. leif.nelin@nationwidechildrens.org., Potenziano JL; Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA.

Publikováno v: BMC pediatrics [BMC Pediatr] 2019 Jan 12; Vol. 19 (1), pp. 17. Date of Electronic Publication: 2019 Jan 12.